Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT00414440 · COMPLETED
Trial details
- NCT number
- NCT00414440
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 431
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.